Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24523N0559
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,196
Award facts
- Contract value 100% obligated
- $12,195.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
On May 11, 2023, the Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $12,195.72 to Otsuka America Pharmaceutical Inc. for the supply of Jynarque 90mg-30mg tablets. The contract utilizes a firm fixed price structure with no set-aside designation and is scheduled for completion by May 16, 2023. This delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and represents a task order under Otsuka's larger Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $83.3 million through March 26, 2026.
Jynarque (tolvaptan) is a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veterans. As a large pharmaceutical manufacturer headquartered in Rockville, Maryland, Otsuka America Pharmaceutical Inc. is an established VA contractor that supplies specialty medications across multiple Veterans Integrated Service Networks. This delivery order supports the VA's mission to provide critical pharmaceutical treatments to veterans and reflects the streamlined procurement capabilities facilitated through the company's established Federal Supply Schedule contracts with the department.
Quick answers
Who was awarded contract 36C24523N0559?
36C24523N0559 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on May 11, 2023.
How much is contract 36C24523N0559 worth?
The government has obligated $12,196 on 36C24523N0559.
Is contract 36C24523N0559 an order under another contract?
Yes. 36C24523N0559 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24523N0559 competed?
The extent of competition for 36C24523N0559 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award